IPOE looking for a possible retracement in March up to 24.70$ (28%+ Upside) with strong resistance at 21$. IPOE is currently sitting above the 50 day SMA line, with the MACD looking to roll over green, and the RSI is oversold. Price action might be heavily variable due to IPOE & Sofi merging this month, negative sentiment in the SPAC market right now, and the possible ripple effect from Clover Health's SEC investigation. This is not financial advice, I am not advocating the buying or selling of IPOE stock.